.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
McKesson
Chubb
Moodys
Novartis
Queensland Health
Farmers Insurance
Fish and Richardson
UBS

Generated: February 25, 2018

DrugPatentWatch Database Preview

Patents Expiring in December 2029

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-006Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Forest Labs LlcNAMZARICdonepezil hydrochloride; memantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL206439-003Jul 18, 2016RXYesNo➤ Sign Up➤ Sign UpMEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-005Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-004Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-003Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-002Nov 13, 2017RXYesYes➤ Sign Up➤ Sign UpY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-001Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Forest Labs LlcNAMZARICdonepezil hydrochloride; memantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL206439-002Dec 23, 2014ABRXYesYes➤ Sign Up➤ Sign UpMEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
Forest Labs LlcNAMZARICdonepezil hydrochloride; memantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL206439-004Jul 18, 2016RXYesNo➤ Sign Up➤ Sign UpMEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
Forest Labs LlcNAMZARICdonepezil hydrochloride; memantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL206439-001Dec 23, 2014ABRXYesNo➤ Sign Up➤ Sign UpMEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Argus Health
McKinsey
Harvard Business School
Deloitte
Moodys
Baxter
Chubb
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot